Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FANLUNG-2
NCT07418866Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Feb 2026
- Primary completion
- Feb 2028
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Fudan University. Primary endpoint: Objective Response Rate at 6 weeks. Planned start Feb 2026; status: not yet recruiting.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07418866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07418866.